Climate Change Economics From a Real Economist

on

In an article entitled Mr. Corcoran, Meet Mr. Orwell, the Financial Post gives Simon Fraser University economist Mark Jaccard space to skewer its own editor, Terence Corcoran.

Jaccard makes all kinds of good sense arguing that a carbon tax would be the most effective way to begin to address the greenhouse gas problem. He also says that Corcoran’s recent “diatribe (to the contrary) reminds me of George Orwell’s Nineteen Eighty-Four, with Mr. Corcoran as Minister of Truth – redefining concepts and rewriting history to accord with his opposition to reducing such greenhouse gas emissions as carbon dioxide.”

Related Posts

on

Cheniere Energy has introduced “cargo emissions tags” to assuage climate concerns of potential buyers. But a new report says these tags are riddled with problems.

Cheniere Energy has introduced “cargo emissions tags” to assuage climate concerns of potential buyers. But a new report says these tags are riddled with problems.
Opinion
on

Anti-science rhetoric and special interests have pushed us to the edge of climate chaos. But just as quantum physics disrupted our view of matter and energy, quantum social change disrupts our beliefs about what’s possible, how fast, and by whom.

Anti-science rhetoric and special interests have pushed us to the edge of climate chaos. But just as quantum physics disrupted our view of matter and energy, quantum social change disrupts our beliefs about what’s possible, how fast, and by whom.
on

Climate campaigners concerned over Jane Toogood’s role in a company that sells technology to produce hydrogen from methane.

Climate campaigners concerned over Jane Toogood’s role in a company that sells technology to produce hydrogen from methane.
on

The Vermont senator nevertheless supported final passage of the Inflation Reduction Act, calling it "a step forward" on climate and drug prices.

The Vermont senator nevertheless supported final passage of the Inflation Reduction Act, calling it "a step forward" on climate and drug prices.